The findings show diligence from the FDA and a need for clinicians to discuss risks, benefits, and unknowns with patients before using drugs with accelerated approval.
Complete DPD deficiency markedly impairs 5-FU catabolism, increasing risk of early severe diarrhea, mucositis, neutropenia, ...
Scientists in Spain say they have uncovered a cure for pancreatic cancer in mice. The breakthrough could help people ...
Morning Overview on MSN
Common painkiller may secretly pack powerful anti-cancer punch
For more than a century, everyday painkillers have been handed over pharmacy counters to ease headaches, joint aches and fevers. Now a wave of research is revealing that some of these familiar tablets ...
An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.
Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...
“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...
Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results